Assessment of early metabolic progression in melanoma patients under immunotherapy: an <sup>18</sup>F-FDG PET/CT study.

EJNMMI Res · 2021 · PMC8426446 · PMID 34495433

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Importantly, survival analysis revealed a longer OS for patients with pseudoprogression compared to those with cPMD; this difference in survival may not be statistically significant, which is very likely attributed to the small number of patients in the pseudoprogression group, but a clear trend was recognized in the respective Kaplan–Meier curves.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.